Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...
Researchers at Phenomix Sciences are using machine learning and genetic risk scoring to investigate emotional hunger, an obesity phenotype linked to emotional and reward-driven eating behaviours. Dr ...
NAMs are now part of early drug discovery, but adoption remains uneven. Join leading experts for a discussion on current applications, limitations and what is required for wider use. The session ...
Researchers have identified metabolic vulnerabilities in Fibrolamellar cancer, a rare liver malignancy affecting adolescents and young adults, using functional profiling and mass spectrometry. The ...
One, an integrated platform combining high-throughput ADME testing with AI-powered human pharmacokinetic projections.
An AI-assisted drug discovery platform using transfer learning has identified a promising gp130 inhibitor for colorectal ...
Scientists at Southwest Research Institute have used AI-driven drug discovery platforms to rapidly identify and synthesise 23 ...
Researchers have developed a scalable bioreactor-based system to produce cardiac organoids that successfully integrated into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results